A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 9,750 shares of BDX stock, worth $2.32 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,750
Previous 10,309 5.42%
Holding current value
$2.32 Million
Previous $2.55 Million 10.67%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$225.07 - $246.17 $125,814 - $137,609
-559 Reduced 5.42%
9,750 $2.28 Million
Q1 2024

Apr 23, 2024

SELL
$233.45 - $247.73 $157,345 - $166,970
-674 Reduced 6.14%
10,309 $2.55 Million
Q4 2023

Feb 01, 2024

SELL
$232.24 - $267.23 $133,770 - $153,924
-576 Reduced 4.98%
10,983 $2.68 Million
Q3 2023

Nov 03, 2023

SELL
$254.9 - $283.59 $3.11 Million - $3.46 Million
-12,199 Reduced 51.35%
11,559 $2.99 Million
Q2 2023

Aug 01, 2023

SELL
$238.39 - $265.32 $180,461 - $200,847
-757 Reduced 3.09%
23,758 $6.27 Million
Q1 2023

May 02, 2023

SELL
$229.71 - $259.35 $1.52 Million - $1.71 Million
-6,598 Reduced 21.21%
24,515 $6.07 Million
Q4 2022

Mar 02, 2023

BUY
$218.29 - $256.91 $190,348 - $224,025
872 Added 2.88%
31,113 $7.91 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $5.61 Million - $6.6 Million
-25,688 Reduced 45.93%
30,241 $7.55 Million
Q3 2022

Oct 25, 2022

SELL
$51.03 - $264.23 $449,115 - $2.33 Million
-8,801 Reduced 13.6%
55,929 $12.5 Million
Q2 2022

Jul 26, 2022

SELL
$234.74 - $275.42 $1.2 Million - $1.41 Million
-5,121 Reduced 7.33%
64,730 $16 Million
Q1 2022

Apr 13, 2022

SELL
$243.64 - $270.48 $4.14 Million - $4.6 Million
-17,002 Reduced 19.58%
69,851 $18.6 Million
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $17.1 Million - $18.6 Million
-74,233 Reduced 46.08%
86,853 $21.8 Million
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $41 Million - $45.2 Million
-176,327 Reduced 52.26%
161,086 $39.6 Million
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $56.3 Million - $61.6 Million
-241,800 Reduced 41.75%
337,413 $82.1 Million
Q1 2021

Apr 14, 2021

SELL
$232.09 - $256.88 $22.4 Million - $24.8 Million
-96,615 Reduced 14.3%
579,213 $141 Million
Q4 2020

Jan 14, 2021

SELL
$221.92 - $245.94 $10.8 Million - $12 Million
-48,747 Reduced 6.73%
675,828 $169 Million
Q3 2020

Oct 15, 2020

SELL
$215.77 - $276.76 $241,662 - $309,971
-1,120 Reduced 0.15%
724,575 $169 Million
Q2 2020

Jul 30, 2020

SELL
$219.9 - $263.41 $1.3 Million - $1.56 Million
-5,929 Reduced 0.81%
725,695 $174 Million
Q1 2020

Apr 15, 2020

BUY
$195.69 - $279.01 $3.37 Million - $4.81 Million
17,243 Added 2.41%
731,624 $168 Million
Q4 2019

Jan 22, 2020

BUY
$236.45 - $266.82 $3.67 Million - $4.14 Million
15,533 Added 2.22%
714,381 $194 Million
Q3 2019

Nov 05, 2019

BUY
$230.58 - $256.08 $1.96 Million - $2.18 Million
8,513 Added 1.23%
698,848 $177 Million
Q2 2019

Aug 09, 2019

BUY
$217.4 - $246.08 $20.2 Million - $22.9 Million
92,932 Added 15.56%
690,335 $174 Million
Q1 2019

Apr 08, 2019

BUY
$206.05 - $248.17 $14.1 Million - $17 Million
68,318 Added 12.91%
597,403 $149 Million
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $11.1 Million - $14 Million
54,224 Added 11.42%
529,085 $119 Million
Q3 2018

Oct 31, 2018

BUY
$233.07 - $256.0 $14.2 Million - $15.5 Million
60,742 Added 14.67%
474,861 $124 Million
Q2 2018

Aug 07, 2018

BUY
$208.1 - $233.85 $56.1 Million - $63 Million
269,589 Added 186.53%
414,119 $99.2 Million
Q1 2018

Apr 20, 2018

BUY
$205.46 - $240.27 $23.2 Million - $27.1 Million
112,958 Added 357.78%
144,530 $31.3 Million
Q4 2017

Feb 08, 2018

BUY
$189.0 - $222.64 $131,733 - $155,180
697 Added 2.26%
31,572 $6.76 Million
Q3 2017

Oct 27, 2017

BUY
$186.89 - $198.9 $934 - $994
5 Added 0.02%
30,875 $6.05 Million
Q2 2017

Aug 07, 2017

BUY
N/A
30,870
30,870 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.